Targeting deposits in amyloidosis
1 Views
administrator
07/08/23
Ashutosh Wechalekar, MBBS, FRCP, FRCPath, University College London Hospitals NHS Trust, London, UK, touches on future approaches for amyloidosis treatment, including targeting amyloid deposits with monoclonal antibodies as well as novel therapies targeting amyloidosis precursor proteins. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).
-
Category
Show more
Facebook Comments
No comments found